Evidence map›Paper›PMID 40671664›Full record

ArticleClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Establishment and Application of Warning Scoring System for Bleeding Severity in Patients with Newly Diagnosed Acute Promyelocytic Leukemia.

Xueqin Li, Hongying Tang, Yu Lian, Wei Liu, Xinyao Liu, Xinlei Yang, Yukai Jing

Abstract read
In one paragraph

Article in Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xueqin LiDepartment of Laboratory Medicine, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital, Taiyuan, China.ORCID 0009-0001-8082-2105
Hongying TangDepartment of Laboratory Medicine, Tianjin Medical University General Hospital, Tianjin, China.ORCID 0009-0000-8661-4414
Yu LianDepartment of Hematology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital, Taiyuan, China.
Wei LiuDepartment of Orthopedics, Inner Mongolia Medical University, Affiliated Hospital of Inner Mongolia Medical University Hohhot City, China.
Xinyao LiuFirst hospital of shanxi medical university, Taiyuan, China.ORCID 0009-0007-0478-8981
Xinlei YangDepartment of Laboratory Medicine, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital, Taiyuan, China.ORCID 0000-0002-1440-6832
Yukai JingDepartment of Laboratory Medicine, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital, Taiyuan, China.ORCID 0000-0001-6409-1157

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Create and evaluate a scoring system to detect early moderate/severe bleeding in acute promyelocytic leukemia (APL).MethodsThe study used 89 APL patients from Shanxi Bethune Hospital (2014/01-2024/10) for development and 48 APL patients from Tianjin Medical University General Hospital (2021/08-2024/08) for validation. Logistic regression was used to analyze independent risk factors and develop a scoring system based on odds ratios, with ROC curves assessing the AUC. Both sets were classified into low and high risk using the system's cut-off, and the incidence of moderate/severe bleeding in each group was calculated. The scoring system's relationship with the ISTH DIC score and their combined diagnostic efficacy for DIC and bleeding events in APL patients were evaluated using AUC, specificity, and sensitivity.ResultsIn the development cohort, 15.7% (14 cases) had moderate/severe bleeding, while the validation cohort had 14.6% (7 cases). Multivariate logistic regression identified LDH levels ≥538 IU/L, fibrinogen <0.95 g/L, and D-Dimer ≥6865 ng/mL as independent risk factors for early moderate/severe bleeding in APL patients. The new warning scoring system had an AUC of 0.899 in the development group and 0.937 in the validation group. High-risk patients in both cohorts were significantly more likely to experience moderate/severe bleeding than low-risk patients (p < .001). The ISTH DIC score is significantly linked to both bleeding severity and the warning scoring system.ConclusionsThe warning scoring system shows potential for predicting the risk of moderate/severe bleeding in APL patients; however, further prospective validation studies are necessary to substantiate its efficacy.

Indexed as

HemorrhageLeukemia, Promyelocytic, AcuteAdolescentAdultAgedFemaleHumansMaleMiddle AgedRisk FactorsSeverity of Illness Indexacute promyelocytic leukemiableedingDICwarning scoring system

Identifiers

PMID40671664
PMCPMC12276516

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.